HomeCompareVGREF vs JNJ

VGREF vs JNJ: Dividend Comparison 2026

VGREF yields 692.28% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VGREF wins by $829123.38M in total portfolio value
10 years
VGREF
VGREF
● Live price
692.28%
Share price
$0.29
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$829123.41M
Annual income
$645,656,795,042.41
Full VGREF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — VGREF vs JNJ

📍 VGREF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVGREFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VGREF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VGREF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VGREF
Annual income on $10K today (after 15% tax)
$58,843.89/yr
After 10yr DRIP, annual income (after tax)
$548,808,275,786.05/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, VGREF beats the other by $548,808,271,748.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VGREF + JNJ for your $10,000?

VGREF: 50%JNJ: 50%
100% JNJ50/50100% VGREF
Portfolio after 10yr
$414561.72M
Annual income
$322,828,399,896.14/yr
Blended yield
77.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VGREF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VGREF buys
0
JNJ buys
0
No recent congressional trades found for VGREF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVGREFJNJ
Forward yield692.28%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$829123.41M$30.5K
Annual income after 10y$645,656,795,042.41$4,749.88
Total dividends collected$814237.51M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VGREF vs JNJ ($10,000, DRIP)

YearVGREF PortfolioVGREF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$79,928$69,228.11$10,594$274.49+$69.3KVGREF
2$602,651$517,128.18$11,294$360.69+$591.4KVGREF
3$4,288,859$3,644,021.75$12,133$476.91+$4.28MVGREF
4$28,825,743$24,236,664.30$13,156$635.42+$28.81MVGREF
5$183,083,222$152,239,676.79$14,432$854.61+$183.07MVGREF
6$1,099,573,723$903,674,675.23$16,056$1,162.76+$1099.56MVGREF
7$6,248,834,638$5,072,290,754.82$18,175$1,604.53+$6248.82MVGREF
8$33,626,094,931$26,939,841,868.20$21,009$2,252.68+$33626.07MVGREF
9$171,464,126,496$135,484,204,920.01$24,911$3,229.73+$171464.10MVGREF
10$829,123,410,393$645,656,795,042.41$30,458$4,749.88+$829123.38MVGREF

VGREF vs JNJ: Complete Analysis 2026

VGREFStock

VIASPACE Green Energy Inc., a renewable energy company, manufacture and sells framed artwork in the United States. It operates through two segments, Framed-Artwork and Grass. The Framed-Artwork segment manufactures copyrighted framed artwork in the People's Republic of China for retail stores. The Grass Segment produces Giant King Grass, a natural hybrid, non-genetically modified, and perennial grass, which is used to generate low carbon and renewable electricity by burning in a biomass power plant; used to produce bio methane through anaerobic digestion; used as a feedstock for non-food liquid biofuels, such as bio ethanol and bio butanol; and used as a feedstock for biochemicals and bio plastics, as well as used as animal feed. The company was founded in 2008 and is headquartered in Marietta, Georgia.

Full VGREF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VGREF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VGREF vs SCHDVGREF vs JEPIVGREF vs OVGREF vs KOVGREF vs MAINVGREF vs ABBVVGREF vs MRKVGREF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.